Implications of MRGPRX2 in human and experimental cardiometabolic diseases
- PMID: 28054574
- PMCID: PMC5523950
- DOI: 10.1038/nrcardio.2016.212
Implications of MRGPRX2 in human and experimental cardiometabolic diseases
Comment in
-
Reply: The complexity of substance P-mediated mast cell activation.Nat Rev Cardiol. 2017 Feb;14(2):124. doi: 10.1038/nrcardio.2016.213. Epub 2017 Jan 5. Nat Rev Cardiol. 2017. PMID: 28054578 No abstract available.
Comment on
-
Mast cells in human and experimental cardiometabolic diseases.Nat Rev Cardiol. 2015 Nov;12(11):643-58. doi: 10.1038/nrcardio.2015.117. Epub 2015 Aug 11. Nat Rev Cardiol. 2015. PMID: 26259935 Review.
References
-
- Shi GP, Bot I, Kovanen PT. Mast cells in human and experimental cardiometabolic diseases. Nat. Rev. Cardiol. 2015;12:643–658. - PubMed
-
- Bot I, et al. The neuropeptide substance P mediates adventitial mast cell activation and induces intraplaque hemorrhage in advanced atherosclerosis. Circ. Res. 2010;106:89–92. - PubMed
-
- Fujisawa D, et al. Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria. J. Allergy Clin. Immunol. 2014;134:622–633.e9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
